Fundraising FoxArtgen Seed Fund
Corporate VCPre-Seed–Seed · 1 people tracked
Find your way into Artgen Seed Fund
Sign up to see every warm intro you have to Artgen Seed Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Artgen Seed Fund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Artgen Seed Fund is a Russian seed-stage venture fund established by Artgen Biotech to back biotech and medtech startups in healthcare. It targets pre-seed (idea, prototype) and seed (preclinical data, MVP) projects in areas such as artificial intelligence, longevity, gene therapy, neuroscience, clinical decision support, digital health, personalized medicine and diagnostics, and oncology. The fund plans to finance up to 10 of the most promising projects per year using convertible loans on founder-friendly terms, with debt forgiveness in case of failure. It also offers industry expertise, mentorship, partner networks, access to clinics and infrastructure, and co-investment support. The fund will reach up to 150 million rubles over three years.
Source: firm website, verified Nov 1, 2026.
Team · 1 people
from the firm's websiteChairman of the Board of Directors of Artgen Biotech, the parent company behind the fund; he describes the fund's mission to provide private seed and angel capital for early-stage Russian startups.
Frequently asked questions
- What stage does Artgen Seed Fund invest at?
- Artgen Seed Fund invests at the Pre-Seed, Seed stages.
- What sectors does Artgen Seed Fund focus on?
- Artgen Seed Fund focuses on AI & Machine Learning, Biotech, Digital Health, EdTech, Healthtech, IoT, Longevity, Medical Devices.
Images
Similar investors
MDI Ventures is the corporate venture arm of Telkom Indonesia, managing a $100 million fund and investing in technology startups, primarily at Series A and beyond.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Karista is a HealthTech-focused investment firm that backs companies across Europe, with an emphasis on leveraging health data to improve clinical outcomes and the economics of care.
MPG Fund is an early-stage venture investor backing technology startups.
Expara is a Southeast Asian early-stage venture capital and venture services firm that also provides acceleration, incubation, entrepreneurship training, and mentorship. Founded in 2003 and headquartered in Singapore, it has launched five VC funds and invested in over 90 companies.